Caburnay, Ideliza S.
HRN: 23-18-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2026
CEFUROXIME 500MG (TAB)
04/20/2026
04/26/2026
PO
500mg
BID
UTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: